Studies related to Symptoms of Carpal Tunnel and Serrapeptase

A Preliminary Trial Of Serratiopeptidase In Patients With Carpal Tunnel Syndrome

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 20
Gender Both Genders
Age Range 30-44, 45-64
Body Types Overweight
Notes for this study:
Supplementation of serrapeptase (20mg) daily after an initial course of nimesulide was able to reduce symptoms of carpal tunnel syndrome in 65% of patients studied, but this trial failed to have a placebo group (and even then, is confounded by the initial course of nimesulide).